Insider · CIK 0001532475

Goldberg Mark Alan

Reports to the SEC for 7 companies · LEXINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001532475

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-07-17	Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,500 sh	—	—	0
2025-07-17	Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,875 sh	—	—	0
2025-07-17	Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,300 sh	—	—	0
2025-07-17	Blueprint Medicines CorpD Disposition to Issuer	Director	DDisposition to Issuer	−3,902 sh	—	—	18,254
2025-07-17	Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,570 sh	—	—	0
2025-07-17	Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10.9K sh	—	—	0
2025-07-17	Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	—	—	0
2025-07-17	Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,500 sh	—	—	0
2025-07-17	Blueprint Medicines CorpU Disposition from Tender	Director	UDisposition from Tender	−18.3K sh	—	—	0
2025-07-17	Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,300 sh	—	—	0
2025-06-18	Blueprint Medicines CorpA Award	Director	AAward	+3,902 sh	$128.12	+$500K	22,156
2024-06-12	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Director	AAward	+4,570 sh	—	—	4,570
2024-06-12	Blueprint Medicines CorpA Award	Director	AAward	+2,242 sh	—	—	18,254
2024-05-01	CBIOCRESCENT BIOPHARMA, INC. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2024-03-29	CBIOCRESCENT BIOPHARMA, INC.A Award	Director	AAward	+4,584 sh	$3.00	+$13.8K	24,828
2024-02-12	ImmunoGen, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2024-02-12	ImmunoGen, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2024-02-12	ImmunoGen, Inc.Deferred Share UnitD Disposition to Issuer	Director	DDisposition to Issuer	−160K sh	—	—	0
2024-02-12	ImmunoGen, Inc.Restricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−13.1K sh	—	—	0
2024-02-12	ImmunoGen, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−19.6K sh	—	—	0
2024-02-12	ImmunoGen, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−60.7K sh	—	—	0
2024-02-12	ImmunoGen, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−44K sh	—	—	0
2024-02-12	ImmunoGen, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−44K sh	—	—	0
2024-02-12	ImmunoGen, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−50K sh	—	—	0
2024-02-12	ImmunoGen, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18K sh	—	—	0
2024-02-12	ImmunoGen, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2024-02-12	ImmunoGen, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18K sh	—	—	0
2024-02-12	ImmunoGen, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2023-12-29	ImmunoGen, Inc.A Award	Director	AAward	+569 sh	$29.65	+$16.9K	60,720
2023-12-29	CBIOCRESCENT BIOPHARMA, INC.A Award	Director	AAward	+5,827 sh	$2.36	+$13.8K	20,244
2023-10-30	ImmunoGen, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$14.70	+$147K	70,151
2023-10-30	ImmunoGen, Inc.M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	$15.08	−$151K	60,151
2023-10-30	ImmunoGen, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2023-09-30	CBIOCRESCENT BIOPHARMA, INC.A Award	Director	AAward	+9,167 sh	$1.50	+$13.8K	14,417
2023-09-29	ImmunoGen, Inc.A Award	Director	AAward	+1,063 sh	$15.87	+$16.9K	60,151
2023-06-30	ImmunoGen, Inc.A Award	Director	AAward	+894 sh	$18.87	+$16.9K	59,088
2023-06-21	Blueprint Medicines CorpA Award	Director	AAward	+2,600 sh	—	—	16,012
2023-06-21	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Director	AAward	+5,300 sh	—	—	5,300
2023-06-14	ImmunoGen, Inc.Stock Option (right to buy)A Award	Director	AAward	+19.6K sh	—	—	19,597
2023-06-14	ImmunoGen, Inc.Restricted Stock UnitA Award	Director	AAward	+13.1K sh	—	—	13,090
2023-05-19	CBIOCRESCENT BIOPHARMA, INC. · Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2023-03-31	ImmunoGen, Inc.A Award	Director	AAward	+4,394 sh	$3.84	+$16.9K	58,194
2022-12-30	ImmunoGen, Inc.Deferred Share UnitA Award	Director	AAward	+3,402 sh	—	—	160,350
2022-09-30	ImmunoGen, Inc.Deferred Share UnitA Award	Director	AAward	+3,530 sh	—	—	156,948
2022-06-30	ImmunoGen, Inc.Deferred Share UnitA Award	Director	AAward	+3,750 sh	—	—	153,418
2022-06-23	Aceragen, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,000
2022-06-21	Blueprint Medicines CorpA Award	Director	AAward	+2,600 sh	—	—	13,412
2022-06-21	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Director	AAward	+5,300 sh	—	—	5,300
2022-06-15	ImmunoGen, Inc.Stock Option (right to buy)A Award	Director	AAward	+44K sh	$3.37	+$148K	44,000
2022-06-15	ImmunoGen, Inc.Deferred Share UnitA Award	Director	AAward	+15K sh	—	—	149,668

Recent filings

Accepted (ET)
Jul 214
Goldberg Mark Alan0001104659-25-069384
SEC(opens sec.gov)
Jun 244
Goldberg Mark Alan0001415889-25-018084
SEC(opens sec.gov)
Jun 144
Goldberg Mark Alan0001415889-24-016981
SEC(opens sec.gov)
May 14
Goldberg Mark Alan0001415889-24-011869
SEC(opens sec.gov)
Apr 24
Goldberg Mark Alan0001415889-24-009744
SEC(opens sec.gov)
Feb 124
Goldberg Mark Alan0001104659-24-014708
SEC(opens sec.gov)

Companies

Address

SYNAGEVA BIOPHARMA CORP. 128 SPRING ST STE 520

LEXINGTON, MA, 02421